Vivos Therapeutics, Inc. Quarterly Goodwill in USD from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Vivos Therapeutics, Inc. quarterly Goodwill history and growth rate from Q4 2019 to Q2 2024.
  • Vivos Therapeutics, Inc. Goodwill for the quarter ending June 30, 2024 was $2.84M, unchanged year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.84M $0 0% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $2.84M $0 0% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $2.84M $0 0% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 $2.84M $0 0% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $2.84M $0 0% Jun 30, 2023 10-Q 2023-08-16
Q1 2023 $2.84M $0 0% Mar 31, 2023 10-Q 2023-06-08
Q4 2022 $2.84M $0 0% Dec 31, 2022 10-K/A 2024-07-30
Q3 2022 $2.84M -$123 0% Sep 30, 2022 10-Q 2022-12-20
Q2 2022 $2.84M -$123 0% Jun 30, 2022 10-Q 2022-12-20
Q1 2022 $2.84M +$172K +6.42% Mar 31, 2022 10-Q/A 2022-11-25
Q4 2021 $2.84M +$172K +6.44% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $2.84M Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $2.84M Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $2.67M Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $2.67M -$434 -0.02% Dec 31, 2020 10-K 2022-03-31
Q4 2019 $2.67M Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.